Saladax Extends Reach of My5-FU Test into Poland, Italy with Distribution Deals | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Saladax Biomedical today announced exclusive distribution deals for its My5-FU diagnostic test in Poland and Italy.

Saladax has appointed Genoxa of Puck, Poland to be its distributor of the test to oncologists in Poland, and AB Analitica of Padua, Italy to distribute the test to hospitals and reference laboratories in Italy.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic mechanism through which some cancers evade the immune system, and more.

The Wall Street Journal reports that Walgreens didn't fully vet Theranos before entering partnership.

Jeremy Berg is to be the next editor in chief of Science magazine.

Regeneron Pharmaceuticals is to be the new sponsor of the prestigious high school Science Talent Search competition, according to the New York Times.